Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Arthritis Rheumatol. 2016 Dec;68(12):2975–2985. doi: 10.1002/art.39828

Table 3.

mRNA expression levels of candidate genes after HDAC5 knockdown in SSc ECs compared to control siRNA-treated cells (mean +/− S.D).

Gene Expression fold change vs. control (n=7 patient pairs) p-value
ID2 2.188 ± 1.002 0.02
CTNNAL1 2.064 ± 0.880 0.03
MBP 4.073 ± 5.550 0.03
PVRL2 3.091 ± 1.600 0.02
CYR61 2.423 ± 1.562 0.03
FSTL1 2.542 ± 1.514 0.04
FSTL3 4.586 ± 4.358 0.03
SQSTM1 2.080 ± 1.419 0.04
KRAS 1.884 ± 1.250 0.08
SOD2 3.446 ± 2.591 0.08
NINJ1 1.849 ± 1.469 0.55
THSD1 1.762 ± 1.106 0.43
FGF18 1.023 ± 1.576 0.35
FAM198 1.086 ± 0.793 0.86
TAB2 1.532 ± 1.017 0.75
TMEM18 1.339 ± 0.688 0.99
IQSEC1 1.301 ± 0.661 0.22
NFYA 1.757 ± 1.622 0.19
ETV5 2.453 ± 2.228 0.83
EDEM1 1.342 ± 0.685 0.35
HSF2 1.807 ± 1.062 0.14
MAP3K3 1.417 ± 0.898 0.55
PRDX3 1.365 ± 0.664 0.31
HSPA2 1.152 ± 0.720 0.31
MATN1 N.D.

N.D.=Not Detected